Autres langues BioLargo, Inc.

Actions

BLGO

US09065A1007

Marché Fermé - OTC Markets Autres places de cotation 21:24:18 28/06/2024			Varia. 5j.	Varia. 1 janv.
0,255 ^USD	-5,87 %		-7,10 %	+51,79 %

11/06	BioLargo, Inc. fabrique les premières cellules de batterie Cellinity, une alternative plus sûre au lithium-ion	CI
14/05	Transcript : BioLargo, Inc., Q1 2024 Earnings Call, May 14, 2024

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

BioLargo, Inc. Manufactures First Cellinity Battery Cells, a Safer Alternative to Lithium-Ion	11/06
BioLargo, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05
BioLargo, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	01/04
BioLargo to Present at The LD Micro Invitational XIV	25/03
New Regulations May Be Coming To Combat Dangerous “Forever Chemicals” – This Cleantech Innovator Is Ready	22/02
Biolargo Equipment Solutions & Technologies, Inc Appoints Sally Gutierrez to the Board of Directors	12/02
BioLargo, Inc. Launches Water Equipment Subsidiary to Capitalize on Opportunities in PFAS and Water Treatment	29/01
BioLargo, Inc. announced that it has received $0.815 million in funding	23/01
BioLargo's PFAS Removal Technology Lands Drinking Water Treatment Project in New Jersey	20/12
BioLargo, Inc. cancelled the transaction announced on December 13, 2022	13/12
BioLargo, Inc. announced that it expects to receive $0.815 million in funding	17/11
BioLargo, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
BioLargo, Inc. to Present at the LD Micro Main Event XVI	19/09/23
BioLargo, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23
BioLargo, Inc. Discusses Record-Breaking Financial Results, Innovation-Pipeline Business Model, and More with The Stock Day Podcast	05/06/23
BIOLARGO, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	18/05/23
BioLargo, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	17/05/23
0:00:05.7 Dennis Calvert: Today. What's up? Dennis Calvert - Form 8-K	09/05/23
BIOLARGO, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	09/05/23
BioLargo to Present at the Sequire Investor Summit in Puerto Rico	24/04/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues BioLargo, Inc.

Actions

BLGO

US09065A1007

Autres langues

Filtres